Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 21Recruiting 10Completed 8Not yet recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 59INDUSTRY 36NIH 3OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 11Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Vomiting 1Ulcer 1Stomatitis 1Skin Cancer Face 1Recurrence 1Pathologic Complete Response 1Parasomnias 1Pain, Intractable 1Ovarian Neoplasms 1Opportunistic Infections 1Neoplasm Metastasis 1Nausea 1Melanoma 1Medulloblastoma 1Lung Neoplasms 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Kidney Neoplasms 1Inflammation 1Hepatitis C, Chronic 1Hepatitis C 1Hematologic Neoplasms 1Glioblastoma 1Fatigue 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1

Interventions

ledipasvir 1Sofosbuvir 1Ribavirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × OTHER_GOV × Recurrence × Clear all
NCT02959359 2017-08-07

DAA in the Risk of Recurrence After Curative Treatment of HCC

Taipei Veterans General Hospital, Taiwan

Phase 4 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡